Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Therapy areas
Immuno-inflammation
Immuno-inflammation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-inflammation
LEO Pharma and Research Project BIOMAP: Towards Personalised Medicine for Inflammatory Skin Diseases
Biospace News
-
April 11, 2019
Immuno-inflammation
Palatin Technologies Announces Positive Top Line Results of Oral Clinical Study of PL-8177 for Ulcerative Colitis and Other Inflammatory Bowel Diseases
Immuno-inflammation
DURECT Announces Patient Dosing in Phase 2a Proof-of-Concept Clinical Trial of Topical DUR-928 in Patients with Mild to Moderate Plaque Psoriasis
Immuno-inflammation
Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis
Immuno-inflammation
Certolizumab Offers 2-Year Durable Response in Treating Plaque Psoriasis: Presented at AAD
Immuno-inflammation
NICE provisionally approves Almirall’s ILUMETRI (tildrakizumab), as a cost effective option...
Firstwordpharma News
-
March 8, 2019
0
Immuno-inflammation
MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval...
Biospace News
-
February 27, 2019
0
Immuno-inflammation
Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus...
Firstwordpharma News
-
February 26, 2019
0
Immuno-inflammation
Aurinia Receives Notice of Allowance from the US Patent and Trademark...
Biospace News
-
February 25, 2019
0
Immuno-inflammation
Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control from Registrational...
Firstwordpharma News
-
February 22, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
MOST POPULAR
Janssen Signs First Two Data Centres to its Haematology Outcomes Network...
April 11, 2019
Bayer to Showcase New Data from its Growing Cancer Portfolio at...
February 5, 2019
Insmed Announces Proposed Public Offering of Common Stock – May 20,...
May 20, 2019
Pfizer Q4: Weak Earnings Projections With Concerns Over Patent Cliffs for...
January 30, 2019
Load more
HOT NEWS
Commercial
Dyne Therapeutics Launches With $50 Million Series A to Treat Muscle...
Commercial
CollPlant Announces Appointment of Jonathan M.N. Rigby as Chairman of the...
Approval
Mylan’s Wixela becomes first generic of GlaxoSmithKline’s Advair approved in US
Commercial
Protagonist Therapeutics to Present at the H.C. Wainwright & Co. Global...
